Upadacitinib CAS 1310726-60-3

Upadacitinib CAS 1310726-60-3

Paub meej
Upadacitinib CAS 1310726-60-3, yog lub qhov ncauj Janus kinase (JAK) inhibitor uas xaiv inhibits JAK1 subtype thiab tawm dag zog los tiv thaiv kev mob los ntawm kev hloov kho lub cev tiv thaiv kab mob.
Indications: Rheumatoid mob caj dab, psoriatic mob caj dab, atopic dermatitis, ulcerative colitis, Crohn tus kab mob, ankylosing spondylitis
Kev faib tawm yam khoom
API
Share to
Xa kev nug
Hauj lwm lawm
Kev tsis

Zhejiang Hengkang Pharmaceutical Co., Ltd. yog ib qho ntawm feem txhim khu kev qha manufacturers thiab lwm tus neeg ntawm upadacitinib cas 1310726-60-3 nyob rau hauv Suav teb, featured los ntawm cov khoom zoo thiab cov kev pab zoo. Thov so assured mus ua lag luam wholesale bulk upadacitinib cas 1310726-60-3 ua nyob rau hauv Suav teb nov los ntawm peb lub hoobkas.

 

Khoom Taw Qhia

 

  • Upadacitinib

Upadacitinib CAS 1310726-60-3

product-300-300

Tshuaj npe

ABT-494; ABT-494 (Upadacitinib) dawb puag; Upadacitinib (ABT-494); ABT-494 (Upadacitinib); Upadacitinib (Rinvoq); ABT-494; AB 494; AB 494; SIB-273

Quanlity qauv

IH

Cov ntaub ntawv tswj hwm

N/A

Ntim qhov loj

25kg / nruas

Kev cia khoom

Tsis ntau tshaj 30 degree

 

Cim npe nrov: Tuam Tshoj upadacitinib cas 1310726-60-3 manufacturers, lwm tus, Hoobkas

Xa kev nug
CDMOKev Pabcuam

Dedicated rau tshiab tshuaj R & D thiab zus tau tej cov APIs thiab intermediates.

Hu rau tam sim no!